Evidence map›Paper›PMID 25697375›Full record

ArticleToxicology and applied pharmacology2015

Permanent uncoupling of male-specific CYP2C11 transcription/translation by perinatal glutamate.

Sarmistha Banerjee, Rajat Kumar Das, Kelly A Giffear, Bernard H Shapiro

Open access · greenAbstract read
In one paragraph

Article in Toxicology and applied pharmacology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Feminization imprinted by developmental growth hormone.Molecular and cellular endocrinology · 2019
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Sarmistha BanerjeeLaboratories of Biochemistry, University of Pennsylvania, School of Veterinary Medicine, 3800 Spruce Street, Philadelphia, PA 19104-6009, USA.
Rajat Kumar DasLaboratories of Biochemistry, University of Pennsylvania, School of Veterinary Medicine, 3800 Spruce Street, Philadelphia, PA 19104-6009, USA.
Kelly A GiffearLaboratories of Biochemistry, University of Pennsylvania, School of Veterinary Medicine, 3800 Spruce Street, Philadelphia, PA 19104-6009, USA.
Bernard H ShapiroLaboratories of Biochemistry, University of Pennsylvania, School of Veterinary Medicine, 3800 Spruce Street, Philadelphia, PA 19104-6009, USA. Electronic address: shapirob@vet.upenn.edu.
University of Pennsylvania · US

Funding

Short-term Training: students in health professional schoolsT35OD010919 · OD · UNIVERSITY OF PENNSYLVANIA · PI Michael Lee Atchison · 2012 to 2026
$1.8M
Hormonal Imprinting Predetermines Developmental Expression of Cytochrome P450sR01HD061285 · NICHD · UNIVERSITY OF PENNSYLVANIA · PI SHAPIRO, BERNARD HARRIS · 2010 to 2014
$1.7M
NICHD NIH HHS HD-061285NICHD NIH HHS R01 HD061285NIH HHS T35 OD010919
6 · The paper itself

Abstract

Perinatal exposure of rats and mice to the typically reported 4mg/g bd wt dose of monosodium glutamate (MSG) results in a complete block in GH secretion as well as obesity, growth retardation and a profound suppression of several cytochrome P450s, including CYP2C11, the predominant male-specific isoform--all irreversible effects. In contrast, we have found that a lower dose of the food additive, 2mg/g bd wt on alternate days for the first 9days of life results in a transient neonatal depletion of plasma GH, a subsequent permanent overexpression of CYP2C11 as well as subnormal (mini) GH pulse amplitudes in an otherwise normal adult masculine episodic GH profile. The overexpressed CYP2C11 was characterized by a 250% increase in mRNA, but only a 40 to 50% increase in CYP2C11 protein and its catalytic activity. Using freshly isolated hepatocytes as well as primary cultures exposed to the masculine-like episodic GH profile, we observed normal induction, activation, nuclear translocation and binding to the CYP2C11 promoter of the GH-dependent signal transducers required for CYP2C11 transcription. The disproportionately lower expression levels of CYP2C11 protein were associated with dramatically high expression levels of an aberrant, presumably nontranslated CYP2C11 mRNA, a 200% increase in CYP2C11 ubiquitination and a 70-80% decline in miRNAs associated, at normal levels, with a suppression of CYP2C expression. Whereas the GH-responsiveness of CYP2C7 and CYP2C6 as well as albumin was normal in the MSG-derived hepatocytes, the abnormal expression of CYP2C11 was permanent and irreversible.

Indexed as

Active Transport, Cell NucleusAge FactorsAlbuminsAnimalsAnimals, NewbornAryl Hydrocarbon HydroxylasesBinding SitesCarrier ProteinsCells, CulturedCytochrome P-450 Enzyme SystemCytochrome P450 Family 2Enzyme InductionFemaleFlavoring AgentsGrowth HormoneHepatocytesAlbuminsAryl Hydrocarbon HydroxylasesCarrier ProteinsCYP2C11 protein, ratCyp2c6v1 protein, ratCyp2c7 protein, ratCytochrome P-450 Enzyme SystemCytochrome P450 Family 2Flavoring AgentsGrowth HormoneMicroRNAsRNA, MessengerSocs2 protein, ratSodium Glutamatesomatotropin-binding proteinStat5b protein, ratSTAT5 Transcription FactorSteroid 16-alpha-HydroxylaseSteroid 21-HydroxylaseSuppressor of Cytokine Signaling ProteinsCYP2C11Growth hormoneMSGSexual dimorphismSOCS2STAT5b

Identifiers

PMID25697375
PMCPMC4374021
OpenAlexW2086150234

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.